Showcase Your Work

Are you currently conducting some exciting work developing or optimizing tumour models for drug discovery and development? If so, our poster session is the perfect place to showcase it!

Bring a poster, network, and showcase your work to your tumour modelling colleagues.

This is an informal session to help you connect with your peers in a relaxed atmosphere to continue forging new and beneficial relationships. With an audience of biopharma experts eager to hear the latest drug delivery innovations, you will have the opportunity to display a poster presenting your own research. Don’t miss out on the chance to connect, learn, and present.

  • Demonstrate your thought leadership in this dynamic field
  • Gain visibility and exposure by showcasing your innovations
  • Engage in meaningful discussions with industry peers to receive direct feedback
  • Attract the attention of industry stakeholders and collaborators
Viewing poster
poster session socialising
Explaining poster

How to Submit Your Poster

  • You must first register your place to attend the 2nd Tumour Models Summit Malmö
  • Submit an abstract for review to showcase your poster during the Scientific Poster Session
  • You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
  • Once approved, bring your approved poster to the summit, ready to facilitate insightful conversations!
  • Scientific Poster Session: Tuesday, 5th May at 10:00 am
  • Abstract Submission Deadline: Monday, 27th April
Submit Your Poster

Explore the Full Event Guide

  • Free* to attend for biotech & pharma
  • 70+ tumour modelling experts from biopharma based in the Nordics, Poland, Czechia, Germany, Austria and Switzerland
  • Dedicated networking with decision-makers through roundtables, panels, and structured networking sessions
  • Data-driven drug developer case studies on in vitro, complex in vitro, in vivo & more across multiple indications & modalities including ADCs, bispecifics, vaccines, cell therapy, and small molecules
  • The only meeting in the Nordics uniting biotech, pharma, and model providers to master cutting‑edge tumour modelling, sharpen vendor selection, and confidently de‑risk preclinical assets
Download the Agenda
ee7 brochure image